Back to search
B

Bristol-Myers Squibb

Probable
BMY·Pharmaceuticals
Also known as:OpdivoEliquis

Political party breakdown

Corporate/PAC contributions by recipient party for Bristol-Myers Squibb.

$401,005
corporate/PAC spending
Republican
$239,500
60%
Democratic
$153,500
38%
Unknown
$6,005
1%
Other
$2,000
0%
Party is taken from the recipient's official filing. Transactions without a disclosed party are labeled Unknown — never inferred.

Where the money went by state

Geographic breakdown of Bristol-Myers Squibb's corporate/PAC contributions. Click a state to see the red/blue split and local recipients.

Dem lean Rep leanDarker = more spending

District of Columbia

$74,500 corporate/PAC to recipients in this state
Democratic
$37,500 · 50%
Republican
$37,000 · 50%
Local recipients
BONNIE WATSON COLEMAN FOR CONGRESS
$6,000
JEFFRIES FOR CONGRESS
$5,000
EMMER FOR CONGRESS
$5,000
KATHERINE CLARK FOR CONGRESS
$5,000
WENSTRUP FOR CONGRESS
$4,000
FRIENDS OF SHERROD BROWN
$2,500
HUDSON FOR CONGRESS
$2,500
SCALISE FOR CONGRESS
$2,500
PEOPLE FOR DEREK KILMER
$2,500
DR. RAUL RUIZ FOR CONGRESS
$2,500
TEXANS FOR JODEY ARRINGTON
$2,500
PETE AGUILAR FOR CONGRESS
$2,500
DON DAVIS FOR NC
$1,500
KEAN FOR CONGRESS INC.
$1,000
FISCHBACH FOR CONGRESS
$1,000
BARRAGAN FOR CONGRESS
$1,000
TENNEY FOR CONGRESS
$1,000
NEVADANS FOR STEVEN HORSFORD
$1,000
AUGUST PFLUGER FOR CONGRESS
$1,000
TONY CARDENAS FOR CONGRESS
$1,000
KAT FOR CONGRESS
$1,000
DIANA FOR CONGRESS
$1,000
BUDDY CARTER FOR CONGRESS
$1,000
ROBIN KELLY FOR CONGRESS
$1,000
State reflects the recipient's reported state. Contributions without a disclosed state are excluded. Showing all available election cycles.

Political footprint

Money associated with Bristol-Myers Squibb, separated by source. No combined totals.

Corporate / PAC
$401,005
221 contributions
Directly attributable to the company or its registered PAC.
Figures reflect committee/PAC spending only. Individual-contributor (Schedule A) data is excluded per FEC commercial-use restrictions. Showing all available election cycles.
Federal only. BuyAligned tracks political money disclosed to the FEC — federal candidates, parties, and PACs. It does not include state- or local-level contributions (e.g., ballot measures, state candidates), which are disclosed to separate state agencies and are out of scope here.

Similar companies by political lean

Consumer competitors of Bristol-Myers Squibb and which way their corporate/PAC money leans.

Top political recipients

Where Bristol-Myers Squibb's corporate/PAC money went.

RecipientTypePartyAmountDate
GUTHRIE FOR CONGRESSCandidateCandidateRepublican$15,000Feb 25, 2025
DR JOHN JOYCE FOR CONGRESSCandidateCandidateRepublican$12,500Feb 25, 2025
HUDSON FOR CONGRESSCandidateCandidateRepublican$10,500Feb 25, 2025
BONNIE WATSON COLEMAN FOR CONGRESSCandidateCandidateDemocratic$8,500Sep 16, 2025
DIANA FOR CONGRESSCandidateCandidateRepublican$8,500Feb 25, 2025
JASON SMITH FOR CONGRESSCandidateCandidateRepublican$8,500Dec 7, 2023
STEVE DAINES FOR MONTANACandidateCandidateRepublican$8,000Jul 23, 2025
MIKE CRAPO FOR US SENATECandidateCandidateRepublican$7,500Jul 23, 2025
SCALISE FOR CONGRESSCandidateCandidateRepublican$7,500Mar 11, 2025
KEVIN MULLIN FOR CONGRESSCandidateCandidateDemocratic$7,500Mar 11, 2025
Showing 1–10 of 132
Page 1 of 14
Advertisement

PAC activity

Political committees affiliated with this company.

Political organizations

Committees reliably associated with this company.

Lobbying activity

Federal lobbying filings disclosed by Bristol-Myers Squibb (LDA / Senate records), kept separate from contributions.

Total disclosed
$22,280,000
Filings
56
Top registrant
BRISTOL-MYERS SQUIBB COMPANY
$19,840,000
Medicare/Medicaid · 51Health Issues · 41Trade (domestic/foreign) · 19Taxation/Internal Revenue Code · 18Copyright/Patent/Trademark · 18
Date
Registrant
Amount
  • 2026-06-30
    2nd Quarter - Report 2026
    MARSHALL & POPP, LLC
    Pharmacy
    $60,000
  • 2026-06-30
    2nd Quarter - Report 2026
    CAPITOL COUNSEL LLC
    Health Issues; Medical/Disease Research/Clinical Labs; Medicare/Medicaid
    $60,000
  • 2026-06-30
    2nd Quarter - Report 2026
    THE MCMANUS GROUP
    Medicare/Medicaid; Health Issues
    $80,000
  • 2026-06-30
    2nd Quarter - Report 2026
    AVENUE SOLUTIONS
    Health Issues; Medicare/Medicaid
    $60,000
  • 2026-06-30
    2nd Quarter - Report 2026
    W STRATEGIES, LLC
    Health Issues
    $50,000
  • 2026-06-30
    2nd Quarter - Report 2026
    WILLIAMS AND JENSEN, PLLC
    Health Issues; Medicare/Medicaid; Trade (domestic/foreign); Pharmacy
    $80,000
  • 2026-06-30
    2nd Quarter - Report 2026
    SPLITOAK STRATEGIES LLC
    Medicare/Medicaid
    $60,000
  • 2026-06-30
    2nd Quarter - Report 2026
    BRISTOL-MYERS SQUIBB COMPANY
    Trade (domestic/foreign); Health Issues; Medicare/Medicaid; Taxation/Internal Revenue Code; Copyright/Patent/Trademark
    $3,160,000
  • 2026-06-30
    2nd Quarter - Report 2026
    TODD STRATEGY GROUP
    Health Issues; Medicare/Medicaid
    $80,000
  • 2026-03-31
    1st Quarter - Report 2026
    MARSHALL & POPP, LLC
    Pharmacy
    $40,000
  • 2026-03-31
    1st Quarter - Report 2026
    W STRATEGIES, LLC
    Health Issues
    $30,000
  • 2026-03-31
    1st Quarter - Report 2026
    WILLIAMS AND JENSEN, PLLC
    Health Issues; Medicare/Medicaid; Trade (domestic/foreign); Pharmacy
    $80,000
  • 2026-03-31
    1st Quarter - Report 2026
    THE MCMANUS GROUP
    Medicare/Medicaid
    $80,000
  • 2026-03-31
    1st Quarter - Report 2026
    BRISTOL-MYERS SQUIBB COMPANY
    Health Issues; Medicare/Medicaid; Taxation/Internal Revenue Code; Copyright/Patent/Trademark; Trade (domestic/foreign)
    $1,320,000
  • 2026-03-31
    1st Quarter - Report 2026
    SPLITOAK STRATEGIES LLC
    Medicare/Medicaid
    $60,000
  • 2026-03-31
    1st Quarter - Report 2026
    CAPITOL COUNSEL LLC
    Health Issues; Medical/Disease Research/Clinical Labs; Medicare/Medicaid
    $40,000
  • 2026-03-31
    1st Quarter - Report 2026
    TODD STRATEGY GROUP
    Health Issues; Medicare/Medicaid
    $50,000
  • 2026-03-31
    1st Quarter - Report 2026
    AVENUE SOLUTIONS
    Health Issues; Medicare/Medicaid
    $60,000
  • 2025-12-31
    4th Quarter - Report 2025
    WILLIAMS AND JENSEN, PLLC
    Health Issues; Medicare/Medicaid; Trade (domestic/foreign); Pharmacy
    $80,000
  • 2025-12-31
    4th Quarter - Report 2025
    BRISTOL-MYERS SQUIBB COMPANY
    Health Issues; Medicare/Medicaid; Taxation/Internal Revenue Code; Copyright/Patent/Trademark; Trade (domestic/foreign)
    $1,250,000
  • 2025-12-31
    4th Quarter - Report 2025
    CROSSROADS STRATEGIES, LLC
    Medicare/Medicaid; Taxation/Internal Revenue Code; Copyright/Patent/Trademark; Trade (domestic/foreign); Health Issues
    $40,000
  • 2025-12-31
    4th Quarter - Report 2025
    THE MCMANUS GROUP
    Medicare/Medicaid
    $80,000
  • 2025-12-31
    4th Quarter - Report 2025
    SPLITOAK STRATEGIES LLC
    Medicare/Medicaid
    $50,000
  • 2025-12-31
    4th Quarter - Report 2025
    TODD STRATEGY GROUP
    Health Issues; Medicare/Medicaid
    $50,000
  • 2025-09-30
    3rd Quarter - Report 2025
    MILLER STRATEGIES, LLC
    Medicare/Medicaid; Health Issues
    $30,000
Lobbying amounts are income/expense figures reported in each LDA filing and are shown per filing, not summed into the contribution totals above. Showing all available years.

Buy me a coffee

If BuyAligned has been useful, a small tip keeps it independent and ad-free.

Secure checkout via Base44 Payments. You can tip without an account.

BuyAligned

Put your money where your values are. BuyAligned makes it easy to see where the companies you buy from send their political dollars — so you can decide which ones deserve yours.

Explore

About

Buy me a coffee

If BuyAligned has been useful, a small tip keeps it independent and ad-free.

Secure checkout via Base44 Payments. You can tip without an account.

This site reports publicly disclosed political-finance data. Inclusion of a company, candidate, committee, or transaction does not imply wrongdoing, endorsement, or a political position.